Peptide supply for functional medicine — protocol-deep, individualized, 503A-first.
Multi-pharmacy 503A access for the protocol breadth functional practices actually need. Operator-led service, not a portal catalog.
Functional medicine is the cleanest philosophical fit for peptide therapy in the entire clinic landscape. The thesis is the same — interventions that target underlying biology rather than masking symptoms, individualized to the patient, layered into a longer-arc protocol rather than dispensed as a one-shot prescription. Most functional medicine practitioners arrive at peptides on their own. The operating problem is sourcing: no single pharmacy carries every compound a functional practice will reasonably want to prescribe across a year of patient work, and most supply partners default to whatever their single pharmacy stocks. Revival RX Partners is built differently — multi-pharmacy 503A relationships specifically so the practitioner is not constrained to one supplier's catalog.
What functional medicine practices actually source through Revival
The functional medicine peptide menu spans more categories than any other clinic type. A med spa can run a successful program on five compounds. A TRT clinic on eight. A functional practice typically wants twenty or more, because the patient panel is broader, dosing is more individualized, and the practitioner thinks in combinations that match a specific patient's biology.
Almost all of this is 503A territory — patient-specific compounding is the right path for individualized dosing, combination preparations where clinically appropriate, and the customized protocols that define the modality. 503B partner pharmacies enter the picture in narrow cases, typically for high-volume in-office injectables like NAD+ where the practice administers product on-site. Revival opens accounts where you need them on either side.
Gut and tissue healing
- BPC-157 — gut lining and soft tissue, often a baseline protocol for GI-focused patients
- KPV — anti-inflammatory peptide fragment, paired with GI work
- Larazotide — investigated for intestinal permeability protocols
Longevity and metabolic
- NAD+ — cellular energy, mitochondrial support, longevity framing
- Epitalon — longevity protocols (availability varies by partner and state)
- Semaglutide and Tirzepatide — GLP-1 and GLP-1/GIP for metabolic intervention
- MOTS-c and other mitochondrial-derived peptides where available
Growth hormone axis
- Sermorelin, Ipamorelin, Tesamorelin, CJC-1295 — growth hormone secretagogues for sleep, body composition, and recovery
Sleep, cognition, immune
- DSIP — delta sleep-inducing peptide
- Selank, Semax — investigated for cognition and anxiolytic protocols (availability varies)
- Thymosin Alpha-1 — immune modulation
- TB-500 — tissue repair and recovery
Availability and dosing vary by pharmacy, state, and prescriber judgment. Revival maps your protocol library to actual partner-pharmacy capability so the practice is not promising a compound a single supplier cannot reliably dispense.
How the account works
A Standard Account with Revival is free to open. No subscription, no monthly minimum, no setup fee. You apply, then book an intro call with Brad Fogeltanz, who runs the relationship personally. On that call he walks through the protocol categories the practice wants to cover, then maps them to the right partner pharmacies — typically multiple 503A partners for a functional practice rather than a single supplier.
Within five business days, partner-pharmacy accounts are opened on your behalf, your protocol library is mapped to the right supply path per compound, and the practice can place its first order. Prescriptions route through Revival's account; partner pharmacies dispense direct to the patient. You pay per order.
Operator-level service is what makes the multi-pharmacy approach actually work. Coordinating across two or three 503A partners is exactly the kind of operational complexity that a portal cannot handle and that drives most functional practitioners back to a single under-equipped supplier. Brad runs that coordination personally — supply continuity, new compound launches inside the partner network, state-specific availability questions, and the operational nuance that protocol-deep practices require.
Why Revival vs. a portal
Most functional medicine practitioners have already tried portal-only suppliers. The pattern is consistent — the catalog looks broad in marketing copy, but as soon as the practice tries to prescribe outside the four or five high-volume compounds, availability collapses. The portal is optimized for the GLP-1 buyer, not the protocol-deep practitioner.
Blue Atlas is a portal. Revival is an operator. Multi-pharmacy 503A relationships are coordinated by a person who has been in the category for years, and the catalog reflects what the partner network can actually dispense rather than what a marketing page claims. For a practice running combination protocols and individualized dosing, that distinction is the difference between a working program and a program that looks broad until a patient asks for something specific.
There is also a clinical conversation dimension. Functional medicine patients ask sophisticated questions. They have read primary literature, followed practitioners on podcasts, and often arrive knowing the names of compounds the average patient has never heard of. The supply partner needs to be able to keep up with that conversation. Brad can.
Pricing — free to open
The Standard Account is free. No subscription, no monthly minimum, no setup fee. You pay per order at the partner pharmacy's published rate plus Revival's margin, which is built into the listed price. Multi-practitioner groups and practices running serious peptide volume can move to the Concierge tier, which is custom-quoted based on order volume and account complexity rather than a fixed monthly fee.
Compliance and operational fit
Compounded peptides are dispensed by licensed 503A and 503B pharmacies under sections 503A and 503B of the FD&C Act, against a valid prescription written by a licensed prescriber after a documented patient evaluation. They are not FDA-approved as new drug products. Patient consent, marketing language, and consultation scripts should all reflect that distinction accurately. The functional medicine community has, on balance, done this well — Revival provides the language and the protocol-specific consent templates to keep it consistent across the practice.
The protocol-depth question is also a compliance question. Pharmacy selection determines what combinations and individualized dosing are realistically deliverable, and supply gaps create their own problems when a patient is expecting a refill on a specific stack. Revival's multi-pharmacy approach is designed to remove that gap so the prescriber can deliver what the protocol calls for.
Functional medicine questions.
Do you support the protocol depth functional medicine actually needs?
Yes — that is the core reason this page exists. Functional practices typically want twenty or more compounds across gut, longevity, growth hormone axis, sleep, cognition, immune, and metabolic work. Revival opens accounts across multiple 503A partner pharmacies specifically so the practitioner is not constrained to a single supplier's catalog.
Which 503A pharmacies do you work with?
Licensed 503A partners whose sterile compounding capability, audit history, and shipping logistics match functional medicine demand. Specific partner relationships are reviewed during the intro call with Brad because the right combination depends on the protocols the practice plans to carry and the states it operates in.
What does it cost to open an account?
Nothing. The Standard Account is free, with no subscription and no monthly minimum. You pay per order at the partner pharmacy rate plus Revival's margin, which is included in the listed price. Concierge is custom-quoted for multi-practitioner groups and high-volume practices.
Can you support combination protocols and individualized dosing?
Yes. Combination preparations and individualized dosing are core 503A capabilities, which is why functional practices live primarily on the 503A side of the regulatory framework. Pharmacy selection determines what combinations are realistically deliverable, and that is part of what Brad maps during onboarding.
How do you handle protocols with limited clinical trial evidence?
Honestly. Most peptides used in functional medicine have meaningful preclinical and mechanistic literature, with varying levels of human trial data. Revival's role is supply — the clinical conversation with the patient belongs to the prescriber, and the framing should reflect the actual evidence base rather than overstate it.
Do you cover compounds like Tesamorelin, Thymosin Alpha-1, or DSIP?
Where partner-pharmacy capability and the regulatory framework allow, yes. Some peptides have wider availability than others, and availability varies by state and by pharmacy. The protocol library Revival builds is mapped to what your selected partners can actually dispense.
Are compounded peptides FDA-approved?
No. They are dispensed by licensed 503A and 503B pharmacies under federal compounding regulations against a valid prescription. Practitioner education, patient consent, and marketing language should reflect that distinction accurately.